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Because of discrepancies in previous reports regarding the role
of glial cell line-derived neurotrophic factor (GDNF) in motoneu-
ron (MN) development and survival, we have reexamined MNs
in GDNF-deficient mice and in mice exposed to increased
GDNF after in utero treatment or in transgenic animals overex-
pressing GDNF under the control of the muscle-specific pro-
moter myogenin (myo-GDNF). With the exception of oculomo-
tor and abducens MNs, the survival of all other populations of
spinal and cranial MNs were reduced in GDNF-deficient em-
bryos and increased in myo-GDNF and in utero treated animals.
By contrast, the survival of spinal sensory neurons in the dorsal
root ganglion and spinal interneurons were not affected by any
of the perturbations of GDNF availability.
In wild-type control embryos, all brachial and lumbar MNs
appear to express the GDNF receptors c-ret and GFRa1 and
the MN markers ChAT, islet-1, and islet-2, whereas only a small
subset express GFRa2. GDNF-dependent MNs that are lost in
GDNF-deficient animals express ret/GFRa1/islet-1, whereas
many surviving GDNF-independent MNs express ret/GFRa1/
GFRa2 and islet-1/islet-2. This indicates that many GDNF-
independent MNs are characterized by the presence of GFRa2/
islet-2. It seems likely that the GDNF-independent population
represent MNs that require other GDNF family members (neur-
turin, persephin, artemin) for their survival. GDNF-dependent
and -independent MNs may reflect subtypes with distinct syn-
aptic targets and afferent inputs.
Key words: motoneurons; cell death; GDNF; spinal cord;
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Glial cell line-derived neurotrophic factor (GDNF) was the first
member of the GDNF family of neurotrophic factors to be
identified and was originally isolated based on its ability to pro-
mote the survival and differentiation of dopaminergic neurons in
primary cultures from embryonic ventral midbrain (Lin et al.,
1993). Since the initial discovery of GDNF, several other family
members with neurotrophic actions have been reported, and
receptors for each of these have also now been described
(Rosenthal, 1999). The GDNF family of receptors are composed
of a complex involving the transmembrane Ret receptor tyrosine
kinase and one or more of at least four glycosyl phosphatidyl-
inositol (GPI) membrane-anchored ligand-binding components,
GFRa1– GFRa4. The four GDNF family ligands all use Ret but
have their own preferred co-receptors (GDNF/a1; neurturin/a2;
artemin/a3; persephin/a4), although some members may also
interact with nonpreferred co-receptors (e.g., GDNF/a2 and
neurturin/a1), albeit with lower efficiency.
One neuronal population that is responsive to some of the
GDNF family members, including GDNF, are somatic motoneu-
rons (MNs). GDNF and neurturin are expressed in skeletal
muscle and Schwann cells of developing and adult mammals
(Henderson et al., 1994; Suter-Crazzolara and Unsicker, 1994;
Choi-Lundberg and Bohn, 1995; Springer et al., 1995; Sánchez et
al., 1996; Wright and Snider, 1996; Nguyen et al., 1998a; Suzuki et
al., 1998; Golden et al., 1999), and Ret and GFRa1 are expressed
in all populations of spinal and cranial MNs that have been
examined so far (Pachnis et al., 1993; Nakamura et al., 1996; Jing
et al., 1996; Treanor et al., 1996; Bisgrove et al., 1997; Trupp et al.,
1997, 1998; Glazner et al., 1998; Golden et al., 1998; Yu et al.,
1998).
These data indicate that GDNF is expressed in cells that
closely interact with developing MNs (skeletal muscle, Schwann
cells) and that receptors for GDNF are expressed on developing
spinal and cranial MNs. GDNF family members can also promote
the survival of MNs in vitro and in vivo, and mouse mutants
deficient in GDNF or GFRa1 are reported to have reduced MN
numbers (Henderson et al., 1994; Soler et al., 1999; Oppenheim et
al., 1995; Li et al., 1995; Yan et al., 1995; Moore et al., 1996;
Sánchez et al., 1996; Cacalano et al., 1998). Although these
various lines of evidence are consistent with the role of GDNF as
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a neurotrophic survival factor for subpopulations of somatic
MNs, several nagging questions remain. For example, muscle-
specific overexpression of GDNF in transgenic mice during em-
bryonic development is reported to result in normal MN numbers
in neonatal mice (Nguyen et al., 1998b), and there are even
discrepancies in the literature as to whether there is any MN loss
at all in either GFRa1-deficient mice (cf. Enomoto et al., 1998
with Cacalano et al., 1998) or in GDNF-deficient mice (cf. Moore
et al., 1996 and Sánchez et al., 1996 with Pichel et al., 1996). It is
also not clear whether the apparent loss of MNs in GDNF- or
GFRa1-deficient mice involves GDNF regulation of survival
versus proliferation, migration, or differentiation of MNs. For
these various reasons, we have undertaken a detailed analysis of
the role of GDNF in the development of mouse MNs.
Figure 1. Transverse sections of E18.5 spinal cord of
GDNF-deficient (2/2) and wild-type (1/1) control
embryos. A–D, Brachial; E–H, thoracic; I–L, lumbar.
Dotted lines delineate the ventral horn. Scale bars: B
(applies to A, B, E, F, I, J ), 200 mm; D (applies to C,
D, G, H, K, L), 100 mm.
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MATERIALS AND METHODS
GDNF-deficient embryos. The GDNF2/2 mutants were derived from
natural or timed mating of GDNF1/2 3 GDNF1/2 mice (from an R29
ES clone on a CD1 background.) The age of the embryos was determined
by the presence of vaginal plug in the pregnant mothers and indicated as
embryonic day 0.5. Embryos were dissected and immediately immersed
in either Bouin’s fixative for a few days (for neuronal counting and
pyknotic analysis) or 4% paraformaldehyde in 13 PBS for 8–16 hr at 4°C
and cryopreserved in 30% sucrose in PBS and sectioned by cryostat at 15
mm. Some of the embryos were freshly frozen on dry ice powder and
sectioned by cryostat at 15 mm. All embryos were genotyped by PCR with
the following primer sets. To detect the GDNF knock-out allele of a 255
bp PCR product, the upper and lower primers used were 59-CGGAGC-
CGGTTGGCGCTACCGG and 59-ACGACTCGGACCGCCATCG-
GTG. To detect the GDNF wild-type allele of 337 bp PCR product, we
used the following primer set: 59-GAGAGGAATCGGCAGGCTG-
CAGCTG and 59-CAGATACATCCACATCGTTTAGCGG.
Myo-GDNF transgenic mice. To examine the effect of increased target-
derived GDNF (and NT-3 or NT-4) on MN survival, we used embryonic
and neonatal animals that overexpress these factors under a muscle-
specific myogenin promoter that drives transgene expression in mice
embryos beginning before the onset of either muscle innervation or the
programmed cell death (PCD) of MNs and which continues to be
expressed postnatally (Nguyen et al., 1998b). Embryos and neonates
from the myo-GDNF transgenic lines examined here express high
amounts of GDNF in muscle (Nguyen et al., 1998b). Brain and spinal
cord from transgenic and wild-type mice were immersion-fixed in Car-
noy’s or Bouin’s solution, paraffin-embedded, sectioned serially (12 mm),
and stained with either thionin or hematoxylin/eosin. Cell counts of
healthy surviving and dying pyknotic MNs were performed as described
below.
In utero treatment with GDNF. BALB/c ByJ mice (The Jackson Lab-
oratory, Bar Harbor, ME) were bred in Wake Forest Medical School
animal facility. On gestation day 14.5 (the morning a vaginal plug was
observed is designated E0.5), pregnant females were anesthetized with
ether, and partial laparotomy was performed under sterile conditions.
One uterus (3–5 embryos) was exposed, and each embryo was injected
with 5 mg of GDNF in 5 or 10 ml of saline (0.9% NaCl, pH 7.2) using a
modified 10 ml gauge Hamilton microsyringe, as described previously
(Houenou et al., 1990, 1994). Injections were made into the amniotic
fluid, embryos were replaced in the uterus, and the mother was allowed
to recover after the abdomen was sutured. Fetuses from the contralateral
uterus were used as controls (saline only). On E18.5, mice were killed
with an overdose of ether, and fetuses were collected by cesarean section.
Spinal cords from control and trophic factor- or saline-treated embryos
were dissected out, fixed in Bouin’s solution, and processed as described
above.
Neuronal counts. Motoneurons were counted in every fifth or tenth
section through each population examined, and the totals were multiplied
by five or ten to give an estimate of total cell numbers. Cell counts were
done blind as to the treatment condition of the embryo/neonate (control
vs experimental) using a well established counting method that effec-
tively eliminates the possibility of counting the same cell (healthy or
pyknotic) twice (Clarke and Oppenheim, 1995). Data for pyknotic MNs
are expressed as per 1000 surviving MNs.
For assessing sensory neurons, cells in every fifth section of the fourth
or fifth lumbar (L4–L5) dorsal root ganglion (DRG) were counted.
Spinal interneurons were counted in every 20 th section through the entire
lumbar enlargement. One lateral half (hemisection) of the spinal cord
was used for counts of interneurons, and neurons located in the dorsal
horn and ventral horn were excluded from these counts. Cranial MNs in
the following motor nuclei were also assessed quantitatively: oculomotor
(III), trigeminal (V), abducens (VI), facial (VII), spinal accessory (XI),
and hypoglossal (XII). Although a major focus in the spinal cord was on
lumbar and brachial MNs, thoracic MNs were also counted in some of the
embryos/neonates. Because the rostrocaudal boundaries of the XI motor
nucleus was difficult to define precisely, MN counts were confined to the
first 1 or 2 cervical segments (C1–C2), and MN numbers were expressed as
the number per section for both XI MNs and cervical spinal MNs.
In situ hybridization. a 35S-UTP-labeled riboprobes complementary to
c-ret, GFRa1, GFRa2, isl-1, isl-2, and ChAT were synthesized according
to the supplier’s protocol (Stratagene, La Jolla, CA) and used for in situ
hybridization as described previously (McMahon et al., 1992). A 0.627 kb
antisense riboprobe for a mouse c-ret cDNA at the 39 untranslated region
(39-UTR) was derived from pMCRET7 cDNA linearized at the Nsi I
position (Pachnis et al., 1993). Antisense riboprobe to mouse GFRa1
was complementary to position 720–1415 (GenBank accession number
AB000800). Two independent riboprobes were used for detection of
GFRa2 transcripts: a 633 bp fragment complementary to rat GFRa2 at
amino acid positions 217–247 (Wang, 1998) or a 190 bp mouse GFRa2
riboprobe corresponding to nucleotide position 1–190 (GenBank acces-
sion number AF002701). Probes complementary to full-length mouse
isl-1 (1.1 kb), rat isl-2 (1.6 kb), and rat ChAT (2.2 kb) cDNAs were
obtained from Drs. Sam Pfaff and Terry Rabbitts. In situ hybridization
studies were performed on cryosections (transverse or sagittal) of E15.5
and E18.5 embryos. For quantitative analysis of the in situ hybridization,
adjacent transverse sections on a single slide were hybridized separately
with two different riboprobes, and slides of GDNF1/1 and 2/2 sections
were processed simultaneously under identical conditions (e.g., the same
stringency of wash and exposure time on emulsion, etc.). Images were
Figure 2. A, Spinal motoneuron numbers (mean 6 SD) on E18.5 in
GDNF-deficient (2/2) and wild-type control (1/1) embryos. Values in
the bars are sample size (embryos). B, The number (mean 6 SD) of
lumbar spinal interneurons and L4 DRG sensory neurons on E18.5 in
GDNF-deficient (2/2) and control (1/1) embryos. C, The number
(mean 6 SD) of cranial MNs on E18.5 in GDNF-deficient (2/2) and
control (1/1) embryos. 1p , 0.05; 2p , 0.01; 3p , 0.005, t tests.
Oppenheim et al. • GDNF and Motoneuron Survival J. Neurosci., July 1, 2000, 20(13):5001–5011 5003
imported into the computer directly using a CG-7 frame grabber to avoid
distortion of signal intensity using the same exposure for all the sections
quantified (Scion Corporation). A stage micrometer was used to calibrate
the scale before the data analysis of images. The values for in situ signals
are expressed as total pixels (area) in the selected region (ventral horn)
and as the average density of pixels in the same region and were
quantified using NIH Image 1.60 based on signals from at least five
images from each of two or three embryos per region per age. The data
are presented as mean pixels or density 6 SD. Statistical significance ( p
value) was calculated by two-tailed Student’s t test.
RESULTS
Spinal and cranial MNs are reduced in
GDNF-deficient mice
Cell counts of spinal MNs on E18.5 revealed a significant loss in
homozygous GDNF-deficient embryos compared to either wild-
type controls or heterozygotes (Figs. 1, 2A). Brachial, thoracic,
and lumbar MNs were reduced by 34, 22, and 37%, respectively.
A detailed developmental analysis of lumbar MNs between E12.5
and E18.5 indicates that initially GDNF-deficient embryos have
MN numbers comparable to controls but that during the major
period of normal cell death (E13.5–E18.5), they lose more MNs
than controls, and this loss is associated with increased numbers
of degenerating (pyknotic) MNs (Table 1). Although not examined
in as much detail, the number of brachial MNs were also compa-
rable in wild-type and GDNF-deficient embryos on E12.5, whereas
by E15.5 and E18.5 the GDNF-deficient embryos had 24 and 34%
fewer MNs, respectively (data not shown). The number of sensory
neurons in the DRG and interneurons in the spinal cord on E18.5
were unaffected in the GDNF-deficient embryos (Fig. 2B).
An analysis of MN numbers along the rostrocaudal axis of the
lumbar spinal cord on E18.5 revealed that most of the MN loss
occurred in the rostral three-fifths of the lumbar enlargement
(Fig. 3A). Because a small amount of normal MN death continues
for a few days after E18.5 (Oppenheim et al., 1986) and because
most of this loss occurs in caudal lumbar regions (Fig. 3), it seems
likely that the apparent restriction of MN loss on E18.5 in
GDNF-deficient embryos to the rostral and intermediate (vs
caudal) lumbar segments is an artifact of not being able to assess
MN numbers postnatally in these embryos because of their em-
bryonic/perinatal death. Although the analysis of MN numbers
shows that there is a significant loss in the GDNF-deficient
embryos, single Nissl-stained transverse sections of the spinal
cord do not always accurately reflect this (Fig. 1) because the loss
is distributed along the entire spinal cord (Fig. 3). However, these
sections do accurately reflect the normal histology and morphol-
ogy of the spinal cord in GDNF-deficient embryos.
Because cranial somatic MNs express c-ret and GFRa1, we
have also examined MN numbers in several of these nuclei. With
the exception of the abducens and oculomotor nuclei, all other
Figure 3. A, The number (mean 6 SD, SD not shown for illustrative
clarity) of motoneurons per section for five equal lengths of lumbar spinal
cord along the rostrocaudal axis on E18.5 (1/1, 2/2) and P2 (1/1). B,
The number (mean 6 SD) of pyknotic motoneurons per section along the
rostrocaudal axis of lumbar spinal cord in wild-type control (1/1) ani-
mals on E18.5 and P2. In A, E18.5 1/1 versus E18.5 2/2; 1p , 0.005;
E18.5 1/1 versus P2 1/1; 2p , 0.01. In B, 1p , 0.05; 2p , 0.01, t tests.
Table 1. The number (mean 6 SD) of healthy and pyknotic lumbar motoneurons in GDNF-deficient mice
E12.5 E13.5 E14.5 E15.5 E16.5 E18.5 P2
Healthy 1/1 4211 6 767 3936 6 339 3688 6 226 3032 6 373 2870 2405 6 251 2290 6 133
(5) (5) (8) (4) (1) (17) (5)
Healthy 2/2 4480 6 790 3890 6 271 3271 6 301* 2595 6 328** 2171 1506 6 151*** —
(3) (5) (7) (4) (2) (15) —
Pyknotic 1/1 21 6 6 52 6 8 74 6 27 83 6 10 41 9 6 3 2 6 0.6
(5) (5) (8) (4) (1) (12) (5)
Pyknotic 2/2 16 6 5 54 6 12 128 6 17* 112 6 13** 66 13 6 2**** —
(3) (5) 7 (4) (1) (11) —
*p , 0.01; **p , 0.001; ***p , 0.002; ****p,0.05.
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cranial motor nuclei examined here exhibit a significant loss of
MNs (trigeminal 25%, hypoglossal 21%, and facial 18%; Fig. 2C).
Taken together, these data indicate that most populations of
spinal and cranial somatic MNs exhibit decreased cell numbers in
GDNF-deficient mice and that this loss is attributable to in-
creased naturally occurring cell death.
Reductions in c-ret-, GFRa1-, and GFRa2-expressing
cells in GDNF-deficient embryos
Although it is clear from the data on surviving and degenerating
MNs that the loss of GDNF results in increased cell death,
because not all MNs die, it was of interest to determine the
phenotype of surviving versus dying MN subpopulations. Be-
cause GDNF is believed to signal primarily via c-ret and GFRa1
(or less effectively via c-ret and GFRa2), we have examined cells
expressing these receptor mRNAs using in situ hybridization.
Additionally, to further characterize the surviving MNs in
GDNF-deficient embryos, we have examined mRNA expression
for ChAT and for the LIM family homeobox nuclear transcription
factors islet-1 and islet-2.
The expression of c-ret in presumptive MNs in the ventral horn
was reduced in the brachial, thoracic, and lumbar regions of E15.5
GDNF-deficient mice (Fig. 4). Because of the normal rostrocau-
dal gradient of MN death in the mouse embryo spinal cord
(Yamamoto and Henderson, 1999), the decrease in c-ret expres-
sion is more apparent in the brachial region at this age. However,
by E18.5 all three regions exhibit a clear loss of c-ret expression in
ventral cells (Fig. 5), and consistent with the cell counts (Fig. 2),
the thoracic region shows less of a loss than brachial or lumbar.
Although regions dorsal to the ventral horn that normally express
c-ret, GFRa1, and isl-1 (see below) also exhibit reduced mRNA
signals, based on our quantification of interneuron numbers at
E18.5 (Fig. 2), this reduction is unlikely to reflect cell death.
In an attempt to quantify the loss of c-ret expression, we have
averaged the total area (pixels) expressing c-ret in the ventral
spinal cord from several embryos in five independent in situ
hybridization experiments. The relative reduction in c-ret expres-
sion in the ventral horn region of E15.5, GDNF-deficient embryos
was 50, 26, and 35% for brachial, thoracic, and lumbar segments,
respectively (Table 2). Except for the lumbar region, the density
of the c-ret signal was also reduced (Table 3). We have no
explanation for the discrepancy in the area versus density data in
the lumbar region at this age. However, by E18.5 both measures
were also significantly reduced in the lumbar segments (data not
shown, but see Fig. 5). These data indicate that the loss of GDNF
results in a significant reduction in c-ret expression in ventral
neurons in all three spinal regions examined. However, some of
the reduction of the c-ret signal in GDNF-deficient embryos
appears to reflect a loss of (or reduced) expression in surviving
MNs. This is especially obvious on E18.5 (Fig. 5). Therefore, the
reduced density measure likely represents both cell loss and a
reduced in situ signal on the remaining MNs.
In vitro biochemical studies have demonstrated that GDNF
binds preferentially to GFRa1 and less efficiently to GFRa2, but
that all GDNF family members can signal through c-ret (Baloh et
al., 1997; Creedon et al., 1997; Trupp et al., 1997). The retention
of many c-ret expressing MNs in GDNF-deficient mice suggests
that their survival may be mediated by other GDNF ligands or by
Figure 4. Expression of c-ret in spinal motoneurons
of embryos on E15.5. Transverse sections of c-ret in
situ hybridization at brachial, thoracic, and lumbar
levels. Arrowheads indicate ventral horn region; ar-
rows indicate vertebra. Scale bar, 100 mm.
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GDNF receptor components other than GFRa1. We first exam-
ined whether the loss of c-ret-expressing cells was correlated with
the loss of GFRa1 or GFRa2 in brachial segments of E15.5
GDNF-deficient embryos. Most MNs in the brachial and lumbar
regions appear to express GFRa1, whereas only a subset express
GFRa2 (Fig. 6). Although reduced significantly, many GFRa1-
expressing MNs remained in the ventral brachial spinal cord of
GDNF-deficient animals (Fig. 6). Based on area measurements
there was a close correlation between the loss of GFRa1 (50%)
and c-ret (50%) expression in GDNF-deficient mice (Table 2). A
similar relationship was also observed in the thoracic region (26%
loss of c-ret and GFRa1). Although the normal expression of
GFRa2 in the brachial ventral horn of wild-type mice is much less
than that of GFRa1 (Fig. 6), there is an apparent increased
expression of GFRa2 in the ventral horn of GDNF-deficient mice
(Fig. 6, Table 2). The low level of GFRa2 expression in wild-type
mice is not attributable to poor hybridization of the probe be-
cause the weak expression signal was confirmed using two inde-
Figure 5. Expression of c-ret in brachial,
thoracic, and lumbar spinal cord on E18.5.
Scale bar, 200 mm. Note the reduced
mRNA signal in surviving MNs compared
to E15.5 (Fig. 4).
Table 2. Quantification (area) of mRNA signal (mean 6 SD) at E15.5
Probes Brachial 1/1 Brachial 2/2 Thoracic 1/1 Thoracic 2/2 Lumbar 1/1 Lumbar 2/2
c-ret 42107.8 6 10943.4* 20009.1 6 4519.8 17500.9 6 3448.8 12937.3 6 4135.2 31064.3 6 8637.9 20171.7 6 4158.7
(6)** (6) (7) (7) (6) (6)
p 5 0.0035*** 50%**** p 5 0.04 74% p 5 0.02
isl-1 26216.8 6 6150.7 18276.6 6 5367.4 21476.4 6 1958.2 19031.1 6 3176.7 32472.9 6 7662.4 16417.7 6 2657.9
(5) (8) (5) (5) (5) (4)
p 5 0.04 70% p 5 0.24 88% p 5 0.007
GFRa1 36664.4 6 7518.8 18368.6 6 2070.9 19778.3 6 2109.3 14578.5 6 2205.2
(5) (3) (6) (7) NA NA
p 5 0.0037 50% p 5 0.001 74%
GFRa2 930.4 6 440.4 2730.5 6 1302.3 2037.0 6 562.8 3547.9 6 447.3
(4) (5) (6) (5) NA NA
p 5 0.03 293% p 5 0.0007 174%
*pixels 6 SD; **sample size; ***p values. ****The percent change in signal in GDNF null mutants relative to wild-type levels that are expressed as 100%.
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pendent riboprobes, and both probes give strong signals in other
embryonic tissues (data not shown).
To determine whether the surviving neurons in the ventral
horn of GDNF-deficient mice were, in fact, differentiating MNs,
we examined the expression of two MN-specific markers, ChAT
and islet (isl-1 and isl-2), by in situ hybridization. The expression
of ChAT appeared to be reduced in tissue sections from E15.5
GDNF-deficient embryos (Fig. 6), and this was confirmed by the
area measurements showing a 50 and 37% reduction in brachial
and thoracic segments, respectively (Table 4). Because this re-
duction in ChAT is comparable in magnitude to the reduction in
c-ret, this indicates that most, if not all, of the surviving c-ret /
ChAT-positive ventral neurons in the GDNF-deficient embryos
are differentiating MNs.
To further determine the phenotype of surviving MNs in the
GDNF-deficient mice, we examined the expression of isl-1 and
isl-2. Whereas isl-2 is MN-specific, isl-1 is strongly expressed in
MNs as well as in a subset of dorsal interneurons in the spinal
cord. There was a reduction in isl-1 expression in the ventral horn
of brachial (30%) and lumbar (50%) segments, but no apparent
loss in the thoracic region of GDNF-deficient embryos (Table 2).
By contrast, there was no apparent reduction in brachial isl-2
expression on E15.5 (Table 4) or in any segmental region of the
ventral horn of E18.5 GDNF-deficient embryos (data not shown);
isl-2 area measures in the ventral horn at all spinal levels on E18.5
were also comparable to wild-type embryos (data not shown).
Because the area measurements for isl-2, c-ret, isl-1, and ChAT
mRNA expression were similar in the brachial ventral spinal cord
of GDNF-deficient embryos, this indicates that the surviving
GDNF-independent MN population expresses isl-2, whereas the
GDNF-dependent MNs are isl-2-negative and isl-1-positive. All
surviving c-ret /GFRa1-expressing brachial MNs in the GDNF-
deficient mice also appear to coexpress isl-1 and isl-2 as well as
show an apparent upregulation of GFRa2 expression (Table 2).
In utero GDNF treatment rescues MNs from cell death
In previous studies, we found that the administration of a single
injection of different putative neurotrophic factors to mouse em-
bryos in utero on E14 was sufficient to significantly reduce the
normal death of spinal MNs when assessed on E18 (Houenou et
al., 1994). In the present study, we observed that GDNF is also
able to rescue both spinal and cranial MNs from cell death when
administered in utero on E14 (Fig. 7). On average, GDNF treat-
ment increased MN numbers on E18.5 by ;21%. Except for the
abducens and oculomotor nuclei (data not shown), all popula-
tions of somatic MNs were rescued from cell death by GDNF.
Lumbar spinal interneurons and sensory (L4 DRG) neuron num-
bers were also unaffected (data not shown). These data suggest
that the survival of subpopulations of most somatic MNs is
regulated by limiting amounts of endogenous GDNF. As de-
scribed below, however, MN numbers can be increased even more
when endogenous levels of muscle-derived GDNF are constitu-
tively increased throughout the period of normal MN cell death.
Figure 6. Expression (in situ hybridization using antisense cRNA
probes) of multiple markers in transverse sections of E15.5 brachial spinal
cord of GDNF-deficient and control embryos. Arrowheads indicate the
ventral horn; arrow indicates dorsal population of isl-1-expressing neu-
rons. Scale bar, 100 mm.
Table 3. Quantification (density) of the c-ret signal (mean 6 SEM) at E15.5
Probe
Brachial Thoracic Lumbar
1/1 2/2 1/1 2/2 1/1 2/2
c-ret 0.31 6 0.02 0.23 6 0.04* 0.34 6 0.08 0.25 6 0.06** 0.26 6 0.05 0.35 6 0.10
(6) (6) (7) (7) (6) (6)
*p , 0.003; **p , 0.03.
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Muscle-specific overexpression of GDNF (myo-GDNF)
in transgenic mice promotes MN survival
Neonatal mice from the transgenic lines expressing high levels of
GDNF under a muscle-specific (myogenin) promoter (Nguyen et
al., 1998b) were found to have a significant increase in spinal and
cranial MNs (Table 5, Fig. 8). By contrast, transgenic mice that
over express NT-3 or NT-4 (Myo-NT-3, myo-NT-4) have MN
numbers comparable to controls. Based on cell counts in cervical
spinal segments (C1–C2) both cervical spinal MNs (control spinal
MNs 5 3.6 6 0.5 per section, n 5 5, vs 8.3 6 2.3 per section, n 5
5, for myo-GDNF animals; p , 0.002) and XI cranial MNs (con-
trol 5 4.7 6 0.6 per section, n 5 5 vs 7.5 6 0.9 per section, n 5 5,
for myo-GDNF; p , 0.005) were increased in P1 transgenic mice.
Consistent with the results from both the GDNF-deficient mice
and the mice after in utero administration of GDNF, MN num-
bers in the abducens and oculomotor nuclei were not affected in
the myo-GDNF transgenic mice. Similarly, sensory (DRG) and
spinal interneurons were also unaffected in the myo-GDNF mice
(Table 5). The increased number of spinal MNs (lumbar 45%,
brachial 42%) in the myo-GDNF mice was considerably greater
than that seen after in utero GDNF treatment (lumbar 22%,
brachial 23%) but was close to the MN loss observed in GDNF-
deficient mice (e.g., 37% loss of lumbar MNs vs a 45% increase in
myo-GDNF mice). Myo-GDNF embryos examined on E15.5,
during the normal cell death period for spinal MNs, had in-
creased numbers of surviving lumbar MNs (3667 6 194, n 5 4 vs
3110 6 183, n 5 4 for controls; p , 0.01) and fewer degenerating
(pyknotic) lumbar MNs (48 6 12, n 5 4 vs 67 6 18, n 5 4; p ,
0.05). This indicates that the overexpression of GDNF increases
MN numbers by preventing programmed cell death.
DISCUSSION
Using three different approaches to perturb GDNF levels in the
developing mouse embryo, we have shown that each of the three
results in an alteration in the number of MNs that survive during
the period of naturally occurring PCD. GDNF-deficient embryos
exhibit reductions in brachial, thoracic, and lumbar MNs and in
MNs in the III, V, VII, XI, and XII cranial motor nuclei, whereas
oculomotor and abducens MNs were unaffected. The overexpres-
sion of GDNF in developing muscle (myo-GDNF transgenics)
and the injection of exogenous GDNF in utero increased MN
survival in all of the same MN populations whose numbers were
reduced in the GDNF-deficient embryos, whereas again oculo-
motor and abducen MNs were unaffected. The perturbation of
GDNF availability specifically affected MNs, in that the survival
of neither sensory (DRG) nor spinal interneurons were altered by
any of the three approaches. The effects of overexpression of
GDNF in the myo-GDNF transgenics was also trophic factor-
specific because MN numbers in myo-NT-3 and myo-NT4/5-
transgenic animals were comparable to wild-type control values.
When considered together, these results provide compelling evi-
dence for the role of GDNF as a physiologically relevant MN
Figure 7. The number (mean 6 SD) of spinal and cranial motoneurons
on E18.5 in mouse embryos treated with GDNF in utero on E14. 1p ,
0.01; 2p , 0.05. E, GDNF-treated; C, Control saline-treated. Numbers in
bars are sample size (embryos).
Table 4. Quantification (area) of the ChAT and isl-2 signal (mean 6 SEM) at E15.5
Probe
Brachial Thoracic
1/1 2/2 1/1 2/2
ChAT 37,162 6 1789 18,524 6 3903* 16,670 6 1825 10,468 6 2555**
(6) (6) (7) (7)
Isl-2 16,805 6 2131 16,150 6 4729
(6) (6) N/A N/A
*p , 0.004; **p , 0.025.
Table 5. The number of neurons (mean 6 SD) in transgenic neonatal mice
Lumbar Brachial DRG INS III V VI VII XII
Control 1718 6 179 1781 6 209 4140 6 330 33,000 6 3500 500 6 121 797 6 27 150 6 24 3258 6 188 1007 6 110
(13) (4) (4) (4) (3) (4) (3) (4) (4)
Myo-GDNF 3142 6 336* 3060 6 247* 3968 6 445 31,000 6 3100 432 6 103 1146 6 126** 158 6 22 3945 6 271** 1410 6 115**
(15) (4) (4) (4) (4) (4) (5) (6) (6)
Myo-NT-3 1852 6 216 1905 6 366 4053 6 307 — — — — — —
(5) (3) (3) — — — — — —
Myo-NT-4 1694 6 187 1823 6 265 4160 6 341 — — — — — —
(4) (3) (3) — — — — — —
*p , 0.001; **p , 0.01.
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survival factor in the developing murine nervous system. How-
ever, because some of these results differ from previous reports
they also raise several questions.
Facial MNs
After neonatal axotomy, mammalian facial MNs exhibit a robust
survival response to treatment with exogenous GDNF (Hender-
son et al., 1994; Zurn et al., 1994; Yan et al., 1995; Oppenheim et
al., 1995). By contrast, genetic deletion of GDNF or its primary
co-receptor GFRa1 are reported to have no effect on the number
of surviving facial MNs when examined in embryonic, neonatal,
and adult animals (Moore et al., 1996; Sánchez et al., 1996;
Cacalano et al., 1998). Using three different approaches to per-
turb GDNF availability, we have consistently observed an ;20%
increase or decrease (depending on whether GDNF was in-
creased or decreased) in the number of facial MNs of embryonic
and neonatal animals. This result is based on the evaluation of
.20 experimental and 30 control animals in which cell counts
were made blind to treatment. Accordingly, we are confident that
the modest but significant alteration of facial MNs observed here
is real. Despite this discrepancy, however, there is agreement
among all the different studies regarding the role of GDNF in the
survival of lumbar and trigeminal MNs, and our results now
extend the MN populations that have been shown to respond to
GDNF to include cervical, brachial, and thoracic spinal MNs and
facial, hypoglossal, and spinal accessory cranial MNs.
Other non-MN populations
None of the three approaches used by us to alter GDNF avail-
ability affected the number of surviving sensory DRG neurons,
spinal interneurons, or oculomotor or abducens MNs. From this,
we conclude that at the embryonic ages examined here GDNF is
not likely to be required for the survival of these populations even
though all three populations express GDNF receptors. Although
a previous study of GDNF-deficient animals reported finding a
20% loss of DRG neurons on P0 (Moore et al., 1996), neonatal
animals deficient in the preferred GDNF co-receptor GFRa1
have normal numbers of DRG neurons (Cacalano et al., 1998;
Enomoto et al., 1998). Because the excess GDNF in the myo-
GDNF transgenic animals is not available to most DRG neurons,
the lack of an effect on sensory neuron numbers in these animals
is to be expected. One likely explanation for the discrepancy
between our results and those of Moore et al. (1996) regarding
sensory neurons is the different ages of the GDNF-deficient
animals examined in the two studies (E18.5 vs P0).
The failure of both oculomotor and abducens MNs to exhibit a
responsiveness to GDNF in any of the three approaches used
here to perturb GDNF availability is surprising in light of the fact
that these MNs express both c-ret and GFRa receptors in the
adult (Trupp et al., 1997; Golden et al., 1998; Glazner et al.,
1998). However, receptor expression has not yet been examined
during development.
GDNF-dependent and independent MNs
There is considerable evidence supporting the idea that the
survival of developing MNs depends on multiple neurotrophic
factors produced by different cell types (Oppenheim, 1996; Han-
son et al., 1998; Arce et al., 1998). This is perhaps not surprising
given that MNs differ phenotypically depending on their location,
peripheral targets, and afferent inputs (Tsuchida et al., 1994; Lin
et al., 1998). The fact that treatment with specific neurotrophic
factors in vitro and in vivo and genetic deletion of specific neuro-
trophic factors and their receptors only affect a proportion of all
MNs in a given population (e.g., lumbar MNs) is consistent with
the idea of MN subpopulations that require distinct trophic
factors for their survival. A striking example of this is the case of
MNs that are responsive to the muscle-derived neurotrophic
factor hepatocyte growth factor/scatter factor (HGF/SF). In both
chicken and rat, only limb-innervating MNs are rescued from
PCD by HGF/SF (Yamamoto et al., 1997; Novak et al., 2000).
The present results are also consistent with this idea in that
Figure 8. Transverse sections of P1 spinal cord from myo-GDNF trans-
genic animals (A, C, E, G, L), controls (B, D, F, H, K ), and myo-NT-3 ( I )
and myo-NT-4 ( J) animals. A–D, Brachial; E–J, lumbar; K, L, cervical.
Scale bars: A (applies to A, B, E, F ), 150 mm; C (applies to C, D, G-J ), 80
mm; K (applies to K, L), 70 mm. Dotted lines in A–J delineate the ventral
horn, and in K and L, the cervical (arrows) and spinal accessory (XI ) MNs.
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although the survival of virtually all MN populations examined by us
(spinal and cranial) are affected by GDNF availability, only a sub-
population (20–40%) in each region or motor nucleus are depen-
dent on GDNF for their survival. Although alternative explanations
of this observation are possible (Oppenheim, 1996), we favor the
notion that these represent distinct MN phenotypes that, based on
their unique pattern of receptor expression, relative to other MNs,
are dependent on GDNF for their survival. This is not meant to
exclude the possibility that these same MNs can also respond to or
are dependent on other neurotrophic factors (Oppenheim et al.,
1993; Oppenheim, 1996; Arce et al., 1998; Hanson et al., 1998).
We find that c-ret and GFRa1 are expressed on most, if not all,
spinal MNs in the developing mouse embryo, whereas only a subset
of these are lost in GDNF-deficient animals, and only a proportion
of the MNs lost during naturally occurring PCD are rescued by
increased availability of GDNF (myo-GDNF and in utero treat-
ment). Thus, there are GDNF-dependent and GDNF-independent
subpopulations of spinal MNs. Based on our similar findings for
cranial MNs (i.e., partial cell losses in each nucleus), these also
appear to be composed of GDNF-dependent and independent sub-
populations. In a recent study that examined the death of spinal
MNs in GFRa1 and GFRa2-deficient mice, a selective vulnerability
of subpopulations was also observed (Garcés et al., 2000). Few if any
MNs were lost in GFRa2-deficient mice (Rossi et al., 1999), whereas
distinct subpopulations were missing in GFRa1-deficient animals.
Examination of the spinal cord of our GDNF-deficient embryos
revealed a loss of c-ret expression comparable to the amount of cell
loss. Although there was a close correlation between the loss of c-ret
and GFRa1 expression in spinal MNs, many GFRa1-expressing
MNs remained in GDNF-deficient embryos. Additionally, the ap-
parent reduction in c-ret expression in surviving MNs of GDNF-
deficient mice on E18.5 suggests that the maintenance of c-ret
expression between E15 and E18 may require GDNF. The expres-
sion of GFRa2 was considerably less than GFRa1 in spinal MNs of
wild-type control embryos (Garcés et al., 2000), and GFRa2 expres-
sion was increased in GDNF-deficient embryos. Accordingly,
GFRa2-expressing MNs represent only a small subset of all MNs
and do not appear dependent on GDNF for their survival.
Our observation that a subpopulation of c-ret /GFRa1-positive
MNs are lost in GDNF-deficient embryos is consistent with the
reported loss of only subsets of spinal MNs in GFRa1-deficient
animals (Cacalano et al., 1998; Garcés et al., 2000) and with
previous reports of partial MN losses in GDNF-deficient em-
bryos (Moore et al., 1996; Sánchez et al., 1996). Our failure to
observe a loss of GFRa2-expressing MNs in GDNF-deficient
embryos is also consistent with GFRa2 being the preferred
co-receptor for neurturin (Klein et al., 1997; Heuckeroth et al.,
1999). Although the survival of cultured rat MNs is promoted by
neurturin (Klein et al., 1997), a quantitative analysis of MNs in
Neurturin or GFRa2-deficient animals has not yet been reported
(Rossi et al., 1999; Heuckeroth et al., 1999). Interestingly, how-
ever, cultured MNs from GFRa2-deficient embryos retain their
responsiveness to both GDNF and Neurturin (Garcés et al.,
2000), suggesting that mouse spinal MNs may actually respond to
Neurturin via receptors other than GFRa2.
To confirm that the surviving cells in the ventral horn of the
GDNF-deficient embryos are in fact MNs, we have used two
specific MN markers, ChAT and islet. There was a reduction in
ChAT expression in the spinal cord of GDNF-deficient embryos
consistent with the cell loss and with the reduced expression of
c-ret /GFRa1. Using separate probes for isl-1 and isl-2, we found
expression of both mRNAs in spinal MNs, whereas isl-1 was also
strongly expressed in a subset of dorsal interneurons. Interest-
ingly, there was a reduction of isl-1 expression in GDNF-deficient
embryos comparable to the observed MN cell loss and to the
reduction in c-ret /GFRa1/isl-1 expression in brachial and lumbar
MNs, whereas there was no apparent loss of isl-2 expression.
From this, we can conclude that the GDNF-dependent MNs
represent a subset of c-ret /GFRa1/isl-1-expressing MNs, whereas
the GDNF-independent MNs are an isl-2-positive subpopulation.
The fact that all surviving c-ret /GFRa1-expressing MNs also
appear to coexpress isl-1 and isl-2 (and show an upregulation of
GFRa2) suggests that these represent a subset of MNs that may
be dependent on other GDNF family members for their survival.
Both neurturin and persephin have been reported to promote the
survival of mammalian and avian MNs (Klein et al., 1997; Op-
penheim et al., 1998; Soler et al., 1999) and therefore may be
trophic factors for these GDNF-independent MNs. We have also
found that another GDNF family member, artemin (Baloh et al.,
1998), can also promote the survival of subpopulations of avian
MNs in vitro and in vivo (R. Oppenheim, unpublished data).
The expression of LIM homeobox genes, including isl-1 and
isl-2, by avian embryo MNs is organized topographically in the
spinal cord such that the combinatorial expression of these genes
define distinct subsets of MNs that reflect their position in the
spinal cord and their peripheral targets (Tsuchida et al., 1994).
Although the expression of LIM homeobox genes in mammalian
MNs is not as well characterized as in the chick, based on the
pattern of expression in the chick, one might predict that the
differential expression of isl-1 and isl-2 among GDNF-dependent
and GDNF-independent mouse MNs may reflect different phe-
notypes regarding peripheral targets or afferent inputs.
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